Zol09 0016 01
Zoledronic Acid Injection, Solution
Product Images NDC 25021-826
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Zoledronic Acid (NDC 25021-826). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Sagent Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Zol09 0016 02
Zol09 0020 03
This is a description of Zoledronic Acid Injection, with each 100 mL bag containing 4 mg of zoledronic acid per 100 mL (0.04 mg per mL) for intravenous infusion. It is advised not to mix with calcium-containing infusion solutions and the infusion time should not be less than 15 minutes. The product is not intended for patients with reduced renal function and should be used as a single dose only. The container and closure are nonpyrogenic, preservative-free, DEHP-free, and PVC-free. Storage temperature should be kept at 20°C to 25°C (68°F to 77°F) with excursions permitted between 15°C to 30°C (59°F to 86°F).*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
